The implementation of Magnetic Resonance Image Guided Radiotherapy (MRgRT) into a Prostate Cancer Program will allow to reproduce the results obtained with state-of-the-art brachytherapy combined with EBRT with the added advantage of convenience.
Eligibility
Sex
MALE
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria:
* Patients with unfavorable intermediate, high and very high risk PCa as per the NCCN stratification criteria .
* Suboptimal candidates for high-dose therapy such as elderly, frail patients or patients with large volume glands (i.e, \>60cm3) or extensive TURP in the prior 6-12 months should be considered cautionary indications.
* Patients with low risk of nodal spread may be treated on a MRI-guided local SBRT program.
Exclusion Criteria:
* No prior radiation therapy to the target areas
* Patient able to undergo a MRI exam
Primary outcome measure(s)
Biochemical relapse-free survival — 5-years To achieve a 5-year biochemical relapse-free survival of 85%.
Trial sites (1)
Facility
City
Region
Status
Clínica Universidad de Navarra Cancer Center
Pamplona
Foral Community of Navarre
More Clinica Universidad de Navarra, Universidad de Navarra trials in Spain
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.